General Drug Private Limited, a active private limited company, was established on 15 April 2008 in Mumbai, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24232MH2008PTC181102. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹2.50 M.
It upholds a compliant status. Employing 22 professional, Its leadership includes Mukesh Mahendrakumar Doshi (Director), Hitesh Doshi Mukeshkumar (Director), Yogesh Mukeshkumar Doshi (Director). Past directors included Dhiren Mahendra Ashar, Mahendra Chatrabhuj Ashar. It holds ₹12.27 Cr open charges and ₹7.50 M settled loans. Its latest AGM occurred on 28 September 2024, with the balance sheet filed on 31 March 2024. It is based at Hira House,1St Floor,381-383, S.V.P. Road Near Lilavati School, Mumbai, Maharashtra, 400004.
U24232MH2008PTC181102
181102
15 April 2008
₹3.00 M
₹2.50 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into General Drug Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mukesh Mahendrakumar Doshi | Director | 11 Oct 2009 | Current |
| Hitesh Doshi Mukeshkumar | Director | 11 Oct 2009 | Current |
| Yogesh Mukeshkumar Doshi | Director | 11 Oct 2009 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
| Pramod Abcsdd | Director | 11 Nov 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
General Drug Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 1.62% increase. The company also saw a substantial fall in profitability, with a 65.38% decrease in profit. The company's net worth moved up by a moderate rise of 0.69%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, General Drug had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹122,737,000.00
₹7,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 20 Dec 2019 | Hdfc Bank Limited | ₹6.85 Cr | Open |
| 27 Nov 2010 | Kotak Mahindra Bank Limited | ₹5.43 Cr | Open |
| 20 May 2010 | Kotak Mahindra Bank Limited | ₹7.50 M | Satisfied |
Explore comprehensive loan charge details -
General Drug has a workforce of 22 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of General Drug, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped General Drug's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Hdfc Bank Limited of Rs. 68.49 M registered on 20 Dec 2019 with Charge ID 100314450 was modified on 31 Jan 2025. was documented.
Progress on General Drug Private Limited last Annual general meeting of members was held on 28 Sep 2024 as per latest MCA records. was documented.
Progress on General Drug Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Progress on A charge with Hdfc Bank Limited amounted to Rs. 68.49 M with Charge ID 100314450 was registered on 20 Dec 2019. was documented.
The activity A charge with Kotak Mahindra Bank Limited of Rs. 54.25 M registered on 27 Nov 2010 with Charge ID 10258688 was modified on 10 Mar 2015. was completed.
Progress on A charge registered on 20 May 2010 via Charge ID 10223266 with Kotak Mahindra Bank Limited was fully satisfied on 19 Jan 2011. was documented.
The CIN of General Drug Private Limited is U24232MH2008PTC181102.
General Drug Private Limited is headquartered at Hira House,1St Floor,381-383, S.V.P. Road Near Lilavati School, Mumbai, Maharashtra, 400004.
General Drug Private Limited was incorporated on 15 April 2008.
The current directors of General Drug Private Limited are
The primary industry of General Drug Private Limited is Trade.
General Drug Private Limited is unlisted.
The authorized capital of General Drug Private Limited is ₹3.00 M, and the paid-up capital is ₹2.50 M.
The compliance status of General Drug Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX